Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Open-label, Extension Study in Children With Inadequately Controlled Partial Onset Seizures to Investigate Long-term Safety and Tolerability of TRI476 (Oxcarbazepine) as Adjunctive Therapy

NCT01051193 is registered in ClinicalTrials.gov with Nobelpharma as lead sponsor.

NCT NCT01051193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01051193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Open-label, Extension Study in Children With Inadequately Controlled Partial Onset Seizures to Investigate Long-term Safety and Tolerability of TRI476 (Oxcarbazepine) as Adjunctive Therapy
Lead sponsor
Nobelpharma
Phase
Phase 2/3
Overall status
Completed
Start date
January 5, 2010
Completion date
September 30, 2019
Enrollment
88 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

partial onset seizures